# IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition

> **NCT07197138** · NA · RECRUITING · sponsor: **Max-Planck-Institute of Psychiatry** · enrollment: 42 (estimated)

## Conditions studied

- Depressive Disorder
- Post-Acute COVID-19 Syndrome

## Interventions

- **DEVICE:** Intermittent theta-burst stimulation (iTBS) using PowerMAG 100 ppTMS

## Key facts

- **NCT ID:** NCT07197138
- **Lead sponsor:** Max-Planck-Institute of Psychiatry
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-11
- **Primary completion:** 2026-05
- **Final completion:** 2027-09
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07197138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07197138, "IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07197138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*